KRASCO College, 289 Greenford Road, London, UB68RE, UK.
Curr Top Med Chem. 2011;11(13):1606-20. doi: 10.2174/156802611796117559.
With advances in stem cell biology, tissue engineering is becoming increasingly powerful for tissue regeneration. Stem cells with capacity of multilineage and self-renewal are an ideal cell source for tissue engineering. This review focus on discussing the potential strategies including stem cell sources, bio-scaffolds, mechanical stimulation, genetic modification and co-culture techniques to direct ocular-lineage differentiation of stem cells for complete or partial eye regeneration and research. Attempts to use embryonic and somatic stem cells as seed cells for ocular tissue engineering have achieved encouraging results. The combination of chemical and physical signals in stem cell microenvironment could be regulated to induce differentiation of the embryonic stem cells into ocular tissue. This paper present here a broad introduction to the stem cell mediated correction of eye ailments and provide extensive references for the interested reader. This paper also looks into the different aspects of using stem cells for drug development for treating eye ailments.
随着干细胞生物学的进步,组织工程技术在组织再生方面变得越来越强大。具有多能性和自我更新能力的干细胞是组织工程的理想细胞来源。本综述重点讨论了潜在的策略,包括干细胞来源、生物支架、机械刺激、遗传修饰和共培养技术,以指导干细胞向眼系分化,用于完全或部分眼睛再生和研究。尝试使用胚胎干细胞和体干细胞作为眼组织工程的种子细胞已经取得了令人鼓舞的结果。可以调节干细胞微环境中的化学和物理信号的组合,以诱导胚胎干细胞分化为眼组织。本文对干细胞介导的眼部疾病矫正进行了广泛介绍,并为感兴趣的读者提供了广泛的参考文献。本文还研究了使用干细胞开发治疗眼部疾病药物的不同方面。